Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1
Journal
Annals of Oncology
Journal Volume
32
Journal Issue
2
Pages
208-217
Date Issued
2021
Author(s)
André F.
Ciruelos E.M.
Juric D.
Loibl S.
Campone M.
Mayer I.A.
Rubovszky G.
Yamashita T.
Kaufman B.
Inoue K.
Pápai Z.
Takahashi M.
Ghaznawi F.
Mills D.
Kaper M.
Miller M.
Conte P.F.
Iwata H.
Rugo H.S.
SDGs
Publisher
Elsevier Ltd
Type
journal article